Henry G. Grabowski

15.9k citations
99 papers · 9.7k indexed · 2 hit papers · h-index 40
Topics
Pharmaceutical Economics and Policy (74 papers)Health Systems, Economic Evaluations, Quality of Life (31 papers)Intellectual Property and Patents (30 papers)

In The Last Decade

Henry G. Grabowski

98 papers receiving 8.7k citations

Hit Papers

The price of innovation: new estimates of drug developmen...20032026201020182003201650010001.5k2.0k2.5k

Peers

Henry G. Grabowski
Comparison fields: 5 of 188
  • Economics and Econometrics 5.6k
  • Management of Technology and Innovation 1.7k
  • Molecular Biology 1.5k
  • Public Health, Environmental and Occupational Health 1.2k
  • Computational Theory and Mathematics 1.2k
Replace Joseph A. DiMasi with:
Joseph A. DiMasi United States
Ronald W. Hansen United States
Iain Cockburn United States
Aaron S. Kesselheim United States
Fabio Pammolli Italy
Massimo Riccaboni Italy
Gerald F. Watts Australia
Steven Simoens Belgium
Peter Reiss Netherlands
Patricia M. Danzon United States
Henry G. Grabowski relative to Joseph A. DiMasi United States Joseph A. DiMasi's profile →
Citations per field
00.5×1.6×
Joseph A. DiMasi · 1×
Citations per year

Countries citing papers authored by Henry G. Grabowski

Since Specialization
Citations

This map shows the geographic impact of Henry G. Grabowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry G. Grabowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry G. Grabowski more than expected).

Fields of papers citing papers by Henry G. Grabowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry G. Grabowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry G. Grabowski. The network helps show where Henry G. Grabowski may publish in the future.

Co-authorship network of co-authors of Henry G. Grabowski

This figure shows the co-authorship network connecting the top 25 collaborators of Henry G. Grabowski. A scholar is included among the top collaborators of Henry G. Grabowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry G. Grabowski. Henry G. Grabowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 1
3
Innovation in the pharmaceutical industry: New estimates of R&D costsbreakdown →
1948
4
Consumer Product Safety Regulation
0
5
Pharmaceutical Patent Challenges and Their Implications for Innovation and Generic Competition
1
6
Do Faster FDA Drug Reviews Adversely Affect Patient Safety? An Analysis of the 1992 Prescription Drug User Fee Act
1
7 49
8 22
9
Are the Economics of Pharmaceutical R&D Changing? Productivity, Patents and Political Pressures
8
10 65
11
The price of innovation: new estimates of drug development costsbreakdown →
2642
12
RETURNS ON R&D FOR 1990s NEW DRUG INTRODUCTIONS
6
13 191
14
The impact of cost-effectiveness on public and private policies in health care: an international perspective
7
15 72
16
Longer Patents for Increased Genetic Competition: The Waxman-Hatch Act After One Decade
8
17
Health Reform and Pharmaceutical Innovation
15
18 440
19
Substitution laws and innovation in the pharmaceutical industry.
13
20
The Effects of Advertising on the Interindustry Distribution of Demand
27

About Henry G. Grabowski

Henry G. Grabowski is a scholar working on Management of Technology and Innovation, Economics and Econometrics and Pharmacology, having authored 99 papers that have together received 9.7k indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (74 papers), Health Systems, Economic Evaluations, Quality of Life (31 papers) and Intellectual Property and Patents (30 papers). The work is most often cited by research in Management of Technology and Innovation (1.7k citations), Economics and Econometrics (5.6k citations) and Pharmacology (1.1k citations). Henry G. Grabowski has collaborated with scholars based in United States, United Kingdom and North Macedonia. Frequent co-authors include Joseph A. DiMasi, Ronald W. Hansen, John M. Vernon, Dennis C. Mueller, Louis Lasagna, Genia Long, David B. Ridley, Margaret Kyle, Richard Mortimer and C. Daniel Mullins. Their work appears in journals such as JAMA, Journal of Clinical Oncology and American Economic Review.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026